0001562180-21-002354.txt : 20210318
0001562180-21-002354.hdr.sgml : 20210318
20210318191703
ACCESSION NUMBER: 0001562180-21-002354
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210316
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Butler John P.
CENTRAL INDEX KEY: 0001591467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 21756012
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-03-16
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001591467
Butler John P.
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
true
true
false
false
CEO and President
Common Stock
2021-03-16
4
A
false
39520.00
0.00
A
1156262.00
D
Common Stock
100000.00
I
Held By Dorothy Butler GRAT November 2019
Common Stock
100000.00
I
Held By John Butler GRAT November 2019
Common Stock
59928.00
I
Held by Dorothy Butler 2019 GRAT
Common Stock
59928.00
I
Held by John Butler 2019 GRAT
Common Stock
31047.00
I
Held by Dorothy Butler Revocable Trust 2007
Common Stock
31047.00
I
Held by John Butler Revocable Trust 2007
As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020. Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date.
/s/ Andrea J. Paul, attorney-in-fact for John P. Butler
2021-03-18